Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
Streptavidin-FITC: Optimized Fluorescent Detection in Biotin
2026-05-31
Streptavidin-FITC from APExBIO empowers high-sensitivity, quantitative fluorescent detection of biotinylated targets across immunohistochemistry, flow cytometry, and advanced trafficking studies. Discover protocol enhancements and troubleshooting strategies that translate recent mechanistic insights into robust, reproducible workflows.
-
CRTC-CREB Axis Senses Proteotoxic Stress via Proteasome Inhi
2026-05-30
This study reveals that the CRTC-CREB transcriptional axis operates as a sensor and effector in response to proteasome inhibition-induced proteotoxic stress in Drosophila. The findings uncover ROS/JNK-mediated CREB activation as a conserved mechanism with implications for neurodegenerative disease and aging-related protein aggregation.
-
HDAC Inhibitors as Suppressors of NUT Carcinoma Transcriptio
2026-05-29
Shiota et al. conducted a high-throughput chemical screen revealing that diverse histone deacetylase (HDAC) inhibitors potently repress NUT-driven oncogenic transcription in NUT carcinoma, a rare and aggressive cancer. Their findings clarify how HDAC inhibition disrupts megadomain function and suggest epigenetic therapies as promising treatment avenues for this lethal malignancy.
-
α-KG Restores HPDLSC Function in Periodontitis via LKB1-AMPK
2026-05-29
This study demonstrates that α-ketoglutarate (α-KG) alleviates inflammation-induced mitochondrial dysfunction and cellular senescence in human periodontal ligament stem cells (HPDLSCs) by activating the LKB1-AMPK pathway. The findings highlight a mechanistic basis for targeting stem cell aging in periodontitis, with implications for improved tissue regeneration in inflammatory microenvironments.
-
Drosophila Keap1 Nuclear Condensates in Oxidative Stress Res
2026-05-28
This study uncovers how Drosophila Keap1 forms nuclear condensates in response to oxidative stress, revealing a mechanism involving intrinsically disordered regions and the modular control of phase separation. These findings extend understanding of Keap1’s nuclear function and highlight condensate biology as a critical aspect of stress signaling and chromatin regulation.
-
Nebivolol Hydrochloride: Benchmark β1-Adrenoceptor Antagonis
2026-05-28
Nebivolol hydrochloride stands as the gold-standard β1-adrenoceptor antagonist for dissecting cardiovascular signaling mechanisms. Its exceptional selectivity and robust performance streamline experimental workflows in cardiovascular pharmacology and hypertension research, enabling reproducible, high-resolution data without off-target interference.
-
Septin4 Intensifies Hypoxic Injury in Cardiomyocytes via HIF
2026-05-27
This study reveals that Septin4 exacerbates cardiomyocyte injury under hypoxia by promoting HIF-1α ubiquitination and degradation through the VHL pathway. These findings clarify a novel molecular interaction in ischemic heart disease, offering insights for therapeutic strategies targeting hypoxia-adaptive responses.
-
MG-262 (Z-Leu-Leu-Leu-B(OH)2): Selective Proteasome Inhibito
2026-05-27
MG-262 (Z-Leu-Leu-Leu-B(OH)2) is a potent, reversible, and cell-permeable proteasome inhibitor that targets the chymotryptic activity of the 26S proteasome. This compound induces cell cycle arrest and apoptosis, providing a valuable tool for apoptosis research and proteasome inhibition assays. Its efficacy and selectivity are demonstrated in multiple in vitro and in vivo models, with well-defined solubility and storage parameters.
-
Multiomics Reveals Crossbreeding Effects on Xingguo Goose Me
2026-05-26
This study integrates transcriptomic and metabolomic analysis to dissect how crossbreeding and sex influence growth and meat quality in Xingguo gray geese. The findings clarify molecular pathways underpinning improved production traits in ternary hybrids, offering new targets for genetic selection and practical breeding strategies.
-
Caspase-8 Fluorometric Assay Kit for Advanced Apoptosis Assa
2026-05-26
Unlock precise detection of IETD-dependent caspase activity with the Caspase-8 Fluorometric Assay Kit. This guide translates recent breakthroughs and expert workflows into actionable strategies for robust apoptosis, drug screening, and neurodegenerative disease research.
-
Mechanistic Insights into Diuron-Induced Acute Renal Injury
2026-05-25
This study provides the first integrated mechanistic analysis of Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) nephrotoxicity, combining network toxicology, transcriptomics, and cell-based assays. The findings reveal JAK2/STAT1 pathway activation as a major driver of Diuron-induced acute kidney injury, offering a foundation for future environmental risk assessment and laboratory toxicology workflows.
-
Gramine Induces Ferroptosis in TNBC via CUL3–MTDH Axis Modul
2026-05-25
The reference study reveals that gramine, a natural indole alkaloid, selectively inhibits triple-negative breast cancer (TNBC) by inducing ferroptosis through disruption of the CUL3–MTDH ubiquitination pathway. These findings elucidate a novel regulatory axis in ferroptosis and support gramine's potential as a promising candidate for targeted TNBC therapy.
-
LNP Structure and Administration Route Shape mRNA Delivery i
2026-05-24
This study demonstrates that both the composition of lipid nanoparticles (LNPs) and their route of administration critically govern mRNA delivery efficacy, immunogenicity, and safety in pregnant mice. The findings provide mechanistic guidance for designing RNA therapeutics during pregnancy, with implications for minimizing maternal immune activation and fetal risk.
-
Redefining mRNA Isolation: Strategic Leverage for Translatio
2026-05-23
This thought-leadership article explores how advanced superparamagnetic Oligo (dT) 25 Beads enable robust, high-fidelity mRNA isolation critical for translational research in neurodegeneration and immunosenescence. Integrating mechanistic insight, competitive benchmarking, and evidence from recent Alzheimer’s disease studies, we provide actionable guidance for researchers aiming to bridge bench to bedside with superior molecular tools.
-
Ceftolozane/Tazobactam: Advancing Therapy Against Resistant
2026-05-22
The referenced study investigates the clinical and mechanistic profile of ceftolozane/tazobactam, a novel cephalosporin/beta-lactamase inhibitor with enhanced activity against multidrug-resistant gram-negative bacteria, notably Pseudomonas aeruginosa and ESBL-producing Enterobacteriaceae. Its pharmacokinetic and pharmacodynamic advantages inform future antibacterial research, especially in the context of evolving resistance.